References
- Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International J of Cancer 127(12):2893-2917 (2010)
- Weber DC, Trofimov AV, Delaney TF, Bortfeld T: A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas. Int J Radiat Oncol Biol Phys 58(5):1596-1606 (2004) https://doi.org/10.1016/j.ijrobp.2003.11.028
- Chung JB, Kim TS, Kim IA, Lee JW, Cho W, Suh TS: The effect of photon energy on the intensity-modulated radiation therapy plan for prostate cancer: a planning study. Korean Phys Soc 59(1):183-188 (2011) https://doi.org/10.3938/jkps.59.183
- Trofimov A, Nguyen PL, Coen JJ, et al: Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison. Int J Radiat Oncol Biol Phys 69(2):444-453 (2007) https://doi.org/10.1016/j.ijrobp.2007.03.018
- Goitein M, Lomax AJ, Pedroni ES: Treating cancer with protons. Physics Today 55(9):45-50 (2002) https://doi.org/10.1063/1.1522215
- Jones B, Burnet N: Radiotherapy for the future - Protons and ions hold much promise. British Medical J 330(7498):979-980B (2005) https://doi.org/10.1136/bmj.330.7498.979
- Goitein M, Lomax AJ, Pedroni ES: Weighing proton therapy's clinical readiness and costs. Physics Today 56(6):13-14 (2003) https://doi.org/10.1063/1.4797136
- Kase Y, Yamashita H, Fuji H, et al: A treatment planning comparison of passive-scattering and intensity-modulated proton therapy for typical tumor sites. J of Radiation Research (2011)
- Nutting CM, Convery DJ, Cosgrove VP, et al: Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer. Int J Radiat Oncol Biol Phys 48(3):649-656 (2000) https://doi.org/10.1016/S0360-3016(00)00653-2
- Lomax A: Intensity modulation methods for proton radiotherapy. Phys Med Biol 44(1):185-205 (1999) https://doi.org/10.1088/0031-9155/44/1/014
- Oelfke U, Bortfeld T: Inverse planning for photon and proton beams. Med Dos 26(2):113-124 (2001) https://doi.org/10.1016/S0958-3947(01)00057-7
- Cella L, Lomax A, Miralbell R: Potential role of intensity modulated proton beams in prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 49(1):217-223 (2001) https://doi.org/10.1016/S0360-3016(00)01368-7
- Steneker M, Lomax A, Schneider U: Intensity modulated photon and proton therapy for the treatment of head and neck tumors. Radiat Oncol 80(2):263-267 (2006) https://doi.org/10.1016/j.radonc.2006.07.025
- Huchet A, Caudry M, Belkacemi Y, et al: Volume-effect and radiotherapy [II]. Part II: volume-effect and normal tissue. Cancer Radiotherapie 7(5):353-362 (2003) https://doi.org/10.1016/S1278-3218(03)00082-9
- Mohan R, Wu Q, Manning M, Schmidt-Ullrich R: Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys 46(3):619-630 (2000) https://doi.org/10.1016/S0360-3016(99)00438-1
- Dearnaley DP, Hall E, Lawrence D, et al: Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. British J of Cancer 92(3):488-498 (2005) https://doi.org/10.1038/sj.bjc.6602301
- Peeters ST, Heemsbergen WD, Koper PC, et al: Doseresponse in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J of Clinical Oncology 24(13):1990-1996 (2006) https://doi.org/10.1200/JCO.2005.05.2530
- Pollack A, Zagars GK, Starkschall G, et al: Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53(5):1097-1105 (2002) https://doi.org/10.1016/S0360-3016(02)02829-8
- Michalski JM, Winter K, Purdy JA, et al: Toxicity after three-dimensional radiotherapy for prostate cancer on RTOG 9406 dose Level V. Int J Radiat Oncol Biol Phys 62(3):706-713 (2005) https://doi.org/10.1016/j.ijrobp.2004.11.028
- Rossi CJ Jr, Slater JD, Yonemoto LT, et al: Influence of patient age on biochemical freedom from disease in patients undergoing conformal proton radiotherapy of organ-confined prostate cancer. Urology 64(4):729-732 (2004) https://doi.org/10.1016/j.urology.2004.04.043
- Vargas C, Fryer A, Mahajan C, et al: Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 70(3):744-751 (2008) https://doi.org/10.1016/j.ijrobp.2007.07.2335
Cited by
- Comparison of the BANGkit™ and the PRESAGE™ gel dosimeters for use with a CCD-based optical CT scanner vol.64, pp.5, 2013, https://doi.org/10.3938/jkps.64.740
- A virtual simulator designed for collision prevention in proton therapy. vol.42, pp.10, 2013, https://doi.org/10.1118/1.4931411
- Dosimetric planning study for the prevention of anal complications after post-operative whole pelvic radiotherapy in cervical cancer patients with hemorrhoids. vol.88, pp.1056, 2013, https://doi.org/10.1259/bjr.20150223
- Dosimetric Comparisons of Intensity-Modulated Radiotherapy, Volumetric Modulated Arc Therapy, Tomotherapy, Stereotactic Radiosurgery, and Proton Therapy for Treatment of Patients with a Vestibular Sch vol.74, pp.4, 2019, https://doi.org/10.3938/jkps.74.389
- Recent advances in radiation therapy and photodynamic therapy vol.8, pp.4, 2021, https://doi.org/10.1063/5.0060424